Drug & medication recalls Moderate risk

HYDROmorphone HCl 30 mg/ in 0 recalled over sterility concerns

Recall date
November 9, 2023
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
SCA Pharmaceuticals, LLC recalls HYDROmorphone HCl 30 mg/30 mL in 0.9% Sodium Chloride Injection, (Concentration = 1mg/mL) 30 mL fill Syringe, Rx only,…
Recall number
D-0410-2024
FDA classification
Class II
Brand / firm
SCA Pharmaceuticals, LLC
Sold / distributed
Nationwide in the USA

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

HYDROmorphone HCl 30 mg/30 mL in 0.9% Sodium Chloride Injection, (Concentration = 1mg/mL) 30 mL fill Syringe, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0303-21, Bar Code 70004030321

Get recall alerts

Free email alert whenever SCA Pharmaceuticals, LLC has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: SCA Pharmaceuticals, LLC